Veracyte (VCYT) Surged on Reporting Strong Earnings [Yahoo! Finance]
Veracyte Full Year 2024 Earnings: EPS Misses Expectations [Yahoo! Finance]
Top 3 Medical Instruments Industry Stocks to Ride the GenAI Boom [Yahoo! Finance]
Veracyte, Inc. (NASDAQ: VCYT) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Veracyte, Inc. (NASDAQ: VCYT) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $45.00 price target on the stock.